Strandgaard S, Barry D I, Paulson O B
Scand J Urol Nephrol Suppl. 1984;79:35-8.
The cerebrovascular effects of the converting enzyme inhibitor captopril were examined after intravenous or intracerebroventricular administration in normotensive and hypertensive rats. Cerebral blood flow (CBF) was measured using the intracarotid 133xenom method in halothane/nitrous oxide anaesthetised animals. Captopril given either way did not influence the absolute value of CBF. The main finding, however, was that following intravenous administration of captopril at a dose of 10 mg/kg, both the lower pressure limit of CBF autoregulation were shifted to lower pressure and the autoregulatory plateau shortened. The lower limit was shifted 20-30 mm Hg, the upper limit 50-60 mm Hg, and the autoregulatory plateau consequently shortened by 20-30 mm Hg. In contrast to the marked effects of intravenous captopril, intracerebroventricular captopril was without effect on CBF autoregulation. The effect of intravenous captopril was thus probably mediated by converting enzyme in the cerebrovascular endothelium.
在正常血压和高血压大鼠中,静脉注射或脑室内注射转化酶抑制剂卡托普利后,检测其对脑血管的影响。在氟烷/一氧化二氮麻醉的动物中,使用颈内动脉133氙法测量脑血流量(CBF)。无论以哪种方式给药,卡托普利均不影响CBF的绝对值。然而,主要发现是,静脉注射10mg/kg剂量的卡托普利后,CBF自动调节的下限压力均下移,自动调节平台缩短。下限下移20 - 30mmHg,上限下移50 - 60mmHg,自动调节平台相应缩短20 - 30mmHg。与静脉注射卡托普利的显著作用相反,脑室内注射卡托普利对CBF自动调节无影响。因此,静脉注射卡托普利的作用可能是由脑血管内皮中的转化酶介导的。